medigraphic.com
ISSN 1561-2937 (Impreso)

2019, Número 1

<< Anterior Siguiente >>

Rev Cubana Cardiol Cir Cardiovasc 2019; 25 (1)


Rehabilitación cardiovascular supervisada en la limitación funcional de la claudicación intermitente tipo IIb de Fontaine

Pérez YLM

Idioma: Español
Referencias bibliográficas: 53
Paginas:
Archivo PDF: 512.14 Kb.


RESUMEN

Introducción y objetivo: La claudicación intermitente tipo IIb de Fontaine causa discapacidad, tiene estrecha relación con la prevalencia y mortalidad por enfermedades cardiovasculares. Evaluar la eficacia de la rehabilitación cardiovascular supervisada sobre la limitación funcional en los claudicantes tipo IIb de Fontaine.
Metodología: Se realizó un estudio de intervención comparativo con los claudicantes en el Hospital “Hermanos Ameijeiras”. La muestra quedó conformada por dos grupos, A y B que realizaron rehabilitación cardiovascular supervisada y terapia con ejercicios ambulatorios, respectivamente.
Resultados: Los tiempos libre de dolor, máximo de deambulación, las distancias libre de dolor y máxima de deambulación aumentaron de manera significativa, a los tres y seis meses de la terapéutica en los pacientes que realizaron rehabilitación cardiovascular supervisada (1,8 ± 0,5 vs 3,0 ± 0,6 vs 4,1 ± 0,8; p=<0,001), (2,6 ± 2,2 vs 3,6 ± 0,7 vs 5,0 ± 0,8; p<0,001), (107 ± 31,6 vs 173 ± 38,0 vs 240 ± 47,1; p<0,001) y (130 ± 32,9 vs 210 ± 40,4 vs 290 ± 46,3; p<0,001), respectivamente. Los pacientes que realizaron rehabilitación supervisada tuvieron un cambio relativo hacia la mejoría del tiempo libre de dolor en dos minutos con 11 segundos, del tiempo máximo de deambulación de dos minutos con seis segundos, de la distancia libre de dolor en un 124,3 % y máxima de deambulación de un 123,1 %.
Conclusiones: La rehabilitación cardiovascular supervisada mejoró la limitación funcional de los claudicantes tipo II b de Fontaine.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Marie D, Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017;69:1465-508. PubMed:PMID:27851991.

  2. Creager MA, Belkin M, Bluth EI; Committee to develop Clinical Data Standards for peripheral atherosclerotic vascular disease. Key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol. 2012;59:294.

  3. Sigvant B, Lundin F, Wahlberg E. The Risk of Disease Progression in peripheral arterial disease is higher than expected: A meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2016;51:395-403. PubMed:PMID:26777541.

  4. Milani RV, Lavie CJ. The role of exercise training in peripheral arterial disease. Vasc Med. 2007;12:351- 358.

  5. Fletcher L. Management of patients with intermittent claudication. Nurs Stand. 2006;20(31):59- 65.

  6. Schorr EN, Treat-Jacobson D, Lindquist R. The relationship between peripheral artery disease symptomatology and ischemia. Nurs Res. 2017;66(5):378-87. PubMed:PMID:28858146.

  7. Coveney AP. The management of peripheral arterial disease (PAD) in primary care Diabete Car. 2003(2).

  8. Saurabh A, Rohit SL, Rohit A. Preventive aspects in peripheral arterial disease. Ther Adv Cardiovasc Dis. 2012;6(2):53-70.

  9. Cassady SL. Peripheral arterial disease: A review of epidemiology, clinical presentation and effectiveness of exercise training. Cardiopulm Phys Ther J. 2004;15(3):6-12.

  10. Fakhry F, Rouwet EV, den Hoed PT, et al. Long term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. Br J Surg. 2013;100:1164–71.

  11. Gardner AW, Parker DE, Montgomery PS, et al. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc. 2014;3:e001107. PubMed:PMID:25237048.

  12. Gardner AW, Parker DE, Montgomery PS, et al. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication:a randomized controlled trial. Circulation. 2011;123:491–8.

  13. Guidon M, McGee H. One-year effect of a supervised exercise programme on functional capacity and quality of life in peripheral arterial disease. Disabil Rehabil. 2013;35:397–404.

  14. Saxton JM, Zwierska I, Blagojevic M, Choksy SA, Nawaz S, Pockley AG.. Upperversus lower-limb aerobic exercise training on health related quality of life in patients with symptomatic peripheral arterial disease. J Vasc Surg. 2011;53:1265–73.

  15. Mohler ER, Bundens W, Denenberg J. Progression of asymptomatic peripheral artery disease over 1 year. Vasc Med. 2012;17:10.

  16. Sieminski DJ, Gardner AW. The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med 1997;2(4):286e91.

  17. Thomas RJ, Balady G, Banka G, Beckie TM, Chiu J, Gokak S. 2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation. A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2018;71:1815-37. PubMed:PMID:29606402.

  18. Gerhard Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;69:e71-126. PubMed:PMID:27851992.

  19. Stewart K, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med. 2002;347:1941-1951.

  20. Malgor RD, Alahdab F, Elraiyah TA, Rizvi AZ, Lane MA, Prokop LJ, et al. A systematic review of treatment of intermittent claudication in the lower extremities. J Vasc Surg. 2015;61:54S–73S. PubMed:PMID:25721067.

  21. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45:S5e67.

  22. Francisco Tadeo GR, Antonio Ramón SG. Enfermedad arterial periférica. Claudicación intermitente. Sanidad y ediciones.2010.

  23. Dermott MM, Liu K, Ferrucci L, Criqui MH, Greenland P, Guralnik JM, et al. Physical performance in peripheral arterial disease: a slower rate of decline in patients who walk more. Ann Intern Med 2006;144:10e20.

  24. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008;(4):CD000990. PubMed:PMID:25037027.

  25. Alqahtani KM, Bhangoo M, Vaida F, Denenberg JO, Allison MA, Criqui MH. Predictors of change in the ankle brachial index with exercise Eur J Vasc Endovasc Surg. 2018;55:398-403. PubMed:PMID:29371037.

  26. Fakhry F, Spronk S, de Ridder M, et al. Long-term effects of structured home-based exercise program on functional capacity and quality of life in patients with intermittent claudication. Arch Phys Med Rehabil. 2011;92:1066–73.

  27. Lin JS, Olson CM, Johnson ES, et al. The ankle brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern med. 2013:333–41.

  28. Parmenter BJ, Dieberg G, Smart NA. Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med.2015;45:231–44. PubMed: PMID:25230780.

  29. Parmenter BJ, Dieberg G, Phipps G, et al. Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med. 2015;20:30–40. PubMed:PMID:25432991.

  30. Pilz M, Kandioler-Honetz E, Wenkstetten-Holub A, et al. Evaluation of 6- and 12-month supervised exercise training on strength and endurance parameters in patients with peripheral arterial disease. Wien Klin Wochenschr. 2014;126:383–9. PubMed:PMID:24825596.

  31. Murphy T, Cutlip D, Regensteiner J, Mohler E. Six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) Study. Circulation. 2012;125:130-9.

  32. Negrín Valdés T, Lage López LM, Hernández Toledo C, Castellanos Gallo L, Fardales Rodríguez R, Santos Pérez A, et al. Programa de entrenamiento físico rehabilitador para pacientes con enfermedad arterial periférica y cardiopatía isquémica. CorSalud [Internet]. 2016 [citado 12 Ago 2017];8:29-3. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/94/235.

  33. Domínguez Choy LO, García Beruvides D, León Roger LG, Negrín Valdés T. Programa de entrenamiento físico rehabilitador de enfermedad arterial periférica en pacientes con enfermedad arterial coronaria en régimen de rehabilitación cardiovascular. Rev Ecuatoriana Cardiol [Internet]. 2016 [citado 12 Ago 2017];2(1). Disponible en: http://www.rec-online.org/programa-de-entrenamiento-fisico-rehabilitador-de-enfermedad-arterial-periferica-en-pacientes-con-enfermedad-arterial-coronaria-en-regimen-de-rehabilitacion-cardiovascular/.

  34. Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2012;123:491-8.

  35. Lane R, Ellis B, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev [Internet]. 2014 [citado 28 Feb 2017];7:CD000990. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000990.pub3/pdf

  36. Garg PK, Liu K, Tian L, Guralnik JM, Ferrucci L, Criqui MH, et al. Physical activity during daily life and functional decline in peripheral arterial disease. Circulation 2009;119(2):251e60.

  37. Parr BM, Noakes TD, Derman EW. Peripheral arterial disease and intermittent claudication: efficacy of short-term upper body strength training, dynamic exercise training, and advice to exercise at home. South African Medical Journal. 2009;99:800-4.

  38. Fokkenrood H, Bendermarcher B, Lauret G, Willigendael EM. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2013;8:1-51.

  39. Frans FA, Bipat S, Reekers JA, Legemate DA, Koelemay MJW. Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication. Br J Surg. 2012;99:16–28.

  40. Gommans LN, Fokkenrood HJ, van Dalen HC, Scheltinga MR, Teijink JA, Peters RJ. Safety of supervised exercise therapy in patients with intermittent claudication. J Vasc Surg. 2015;61:512–518. PubMed:PMID:25441008.

  41. Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JA, Hoffmann WH, et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA 2015;314:1936–44. PubMed:PMID:26547465.

  42. Mays RJ, Hiatt WR, Casserly IP. Community-based walking exercise for peripheral artery disease: an exploratory pilot study. Vasc Med. 2015;20:339–47. PubMed:PMID:25755148.

  43. Hageman D, Fokkenrood HJ, Gommans LN, van den Houten MM, Teijink JA. Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication. 2018;4:CD005263. doi: 10.1002/14651858.CD005263.pub4.

  44. Lauret GJ, Fakhry F, Fokkenrood HJP, Hunink MGM, Teijink JAW, Spronk S. Modalidades del entrenamiento con ejercicios para la claudicación intermitente. 2014. Cochrane library.

  45. Mays RJ, Rogers RK, Hiatt WR. Community walking programs for treatment of peripheral artery disease. J Vasc Surg. 2013;58:1678–87.

  46. McDermott MM, Guralnik JM, Criqui .H, et al. Home-based exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial. J Am Heart Assoc 2014.3:e000711. PubMed:PMID:24850615.

  47. Simmons KR, Sinning MA, Pearson JA, Hendrix C. Implementing a home-based exercise prescription for older patients with peripheral arterial disease and intermittent claudication: A quality improvement project. J Vasc Nurs. 2013;31(1):2-8.

  48. Parmen BJ, Raymond J, Dinnen P, Fiatarone Singh MA. A systematic review of randomized controlled trials: Walking versus alternative exercise prescription as treatment for intermittent claudication. Atherosclerosis. 2011;218:1-12.

  49. Leng GC, Fowler B, Ernst E. Ejercicios para la claudicación intermitente (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2008 Issue 3. Chichester, UK: John Wiley & Sons, Ltd.).

  50. Popplewell MA., Bradbury AW. Why do health systems not fund supervised exercise programmes for intermittent claudication?. Eur J Vasc Endovasc Surg. 2014;48:608–10. PubMed:PMID:25176619.

  51. Pérez Yánez LM, Gutiérrez López A. Rehabilitación cardiovascular en pacientes con claudicación intermitente. CorSalud [Internet]. 2017 [citado 12 Ago 2017];9:106-13. Disponible en: http://scielo.sld.cu/pdf/cs/v9n2/cs07217.pdf.

  52. Doménech A. El ejercicio como tratamiento de pacientes con claudicación intermitente de los miembros inferiores de origen vascular. Rev Argent Cardiol. 2007;75(6):1850-3748.

  53. McDermott MM, Kiang Liu, Luigi Ferrucci, Lu Tian, Jack M et al. Greater sedentary hours and slower walking speed qutside the home predict faster declines in functioning and adverse calf muscle changes in peripheral arterial disease. J Am Coll Cardiol. 2011;57:2356-64.




2020     |     www.medigraphic.com